Top articles of the week from The American Journal of Pharmacy Benefits.
5. Link Between Diabetes, Cardiovascular Disease Guide Current Clinical Trials
Patients with diabetes are significantly more likely to develop cardiovascular disease than nondiabetic patients. Read more.4. Novel ADHD Digital Therapy Shows Promise
Children with ADHD treated with AKL-T01 showed a significant positive improvement in attention. Read more.
3. Once-Weekly Semaglutide Approved for Type 2 Diabetes
The FDA issued approval to semaglutide injection (Ozempic) for type 2 diabetes. Read more.2. Blood-Brain Barrier May Present Treatment Target in Multiple Sclerosis
Targeting specific transportation system across the damaged blood-brain barrier could halt MS disease progression. Read more.1. Congenital Heart Disease Screening Prevents Infant Deaths
Pulse oximetry found to reduce infant death from congenital heart disease by 33%. Read more.